A phase II efficacy study of IPP 204106 in the treatment of patients with cancer.
Latest Information Update: 10 Oct 2012
At a glance
- Drugs IPP 204106 (Primary)
- Indications Cancer
- Focus Biomarker; Therapeutic Use
- 10 Oct 2012 New trial record
Latest Information Update: 10 Oct 2012